Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.5 USD | -0.94% | -2.61% | +6.42% |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
05-22 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.42% | 164B | |
+38.69% | 728B | |
+33.59% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.81% | 244B | |
+7.60% | 207B | |
-5.56% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Transcript : Amgen Inc., Q4 2023 Earnings Call, Feb 06, 2024